AVMA news
Zoetis receives $15.3M grant to improve livestock health in Africa
Zoetis announced in March that the company received a $15.3 million grant from the Bill & Melinda Gates Foundation to further develop and integrate…
AVMA news
Panel takes One Health approach to combating antimicrobial resistance
The executive director of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) briefed the AVMA House of Delegates…
JAVMA news
FDA issues booklet reviewing information on animal health care needs
The Center for Veterinary Medicine within the Food and Drug Administration published a pamphlet in August titled "FDA and the Veterinarian."
AVMA news
FDA proposes framework for collecting antimicrobial use data
The Food and Drug Administration’s Center for Veterinary Medicine is inviting public comment on a possible framework for establishing a public-private…
JAVMA news
Reserves of human-use rabies vaccine could alleviate supply worries
An uptick in rabies infections, a swing in the human plasma market, or failure of a human-use vaccine lot to pass regulations could further hurt the…
AVMA news
FDA: Congress, not rule-making, likely route for CBD availability
With the cannabidiol products market continuing to grow and after reviewing published scientific literature and information submitted to a public…
AVMA news
USDA funds antimicrobial resistance dashboard research
The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service has awarded more than $3.2 million to several universities to develop…
AVMA news
FDA creates guidance on informed consent for companion animal studies
The U.S. Food and Drug Administration (FDA) has announced draft guidance that will help animal owners who are considering having their companion…
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
JAVMA news
Human rabies vaccines temporarily limited
IMOVAX Rabies, a rabies vaccine manufactured by Sanofi Pasteur, will be temporarily unavailable for pre-exposure prophylaxis in the United
AVMA news
Midwest Veterinary Supply sentenced to one year probation, pays $11M for misbranded drugs
Minnesota-based drug company Midwest Veterinary Supply recently was sentenced to one year of probation and agreed to pay more than $11 million in…
AVMA news
AVMA testifies in support of improving new animal drug review efficiency
AVMA President Lori Teller appeared before a House subcommittee to urge reauthorization of legislation supporting approval of new and generic animal…
AVMA news
House Committee advances AVMA-backed xylazine language
The Administration announced its national coordinated response on July 11 to fight the deadly combination of illicit xylazine mixed with fentanyl.
JAVMA news
A time of transition at the FDA Center for Veterinary Medicine
Dr. Stephen F. Sundlof became the director of the FDA Center for Food Safety and Applied Nutrition, effective Jan. 7, after serving for more than a…
AVMA news
EPA confirms registration, safety of Seresto collar
The U.S. Environmental Protection Agency (EPA) confirmed the registration and affirmed the safety profile of the Seresto flea and tick collar after a…
AVMA news
FDA warns manufacturers, distributors of unapproved antimicrobials for animals
The U.S. Food and Drug Administration (FDA) on December 14 announced it has issued nine warning letters to manufacturers and distributors of…
AVMA news
FDA approves generic doramectin topical solution for cattle
The Food and Drug Administration has approved DectoGard, the first generic doramectin topical solution for treatment and control of parasites in…
AVMA news
Illicit xylazine, fentanyl combination decreed ‘emerging threat’
The Biden administration designated fentanyl combined with xylazine as an “emerging threat” to the U.S. on April 12, which will allow the federal…
AVMA news
Bill seeks to strengthen US foreign animal disease response
Bipartisan legislation would increase funding, up to $265 million, for federal programs aimed at preventing and combating destructive foreign animal…
AVMA news
A research facility ahead of its time
The state-of-the-art National Bio and Agro-Defense Facility, based in the nation’s heartland, is arguably the most advanced animal agriculture…
AVMA news
Four veterinary scientists recognized with AVMA research awards
The AVMA honored Drs. Jim E. Riviere, Nicholas (Nick) Jeffery, Natasha Olby, and Boaz Arzi with 2023 AVMA Excellence Awards for contributions to…
AVMA news
AVMA members press Congress for illicit xylazine, dog importation laws
Nearly 120 veterinarians and veterinary students attended the 2023 AVMA annual legislative fly-in, held April 17-19 in Washington, D.C. They urged…
blog
Advocacy update: Illicit xylazine, retirement saving, and budget wins
What's happening in Washington, D.C., that affects you? The AVMA's Capitol Hill update outlines some of the most recent developments.
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
AVMA news
North Carolina law will require veterinarians to report gabapentin use
As part of Governor Roy Cooper’s North Carolina Opioid Action Plan, a new law will require the state’s veterinarians to report the use of gabapentin…